The absorption of sulindac from two different 200 mg oral dosage forms
, Pro-Sorb(TM) liquid and Clinoril(R) tablets, was compared following
administration to eight healthy human volunteers. Subjects received bo
th formulations according to a randomized crossover design and blood s
amples were collected at selected times during 24 h. Concentrations of
both sulindac and its active sulphide metabolite were determined by H
PLC and individual serum concentration versus time profiles were const
ructed. Maximal serum concentrations (C-max) and area under the curve
values (AUC(last) and AUC(0-infinity)) were compared for both sulindac
and sulindac sulphide. The results indicate that the rate and extent
of absorption of sulindac from Pro-Sorb(TM) liquid are significantly g
reater than those from Clinoril(R) tablets, a finding consistent with
the observation that the liquid form produces less gastric irritation
following oral administration.